• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种海洋分枝杆菌天然生长的定量研究 为抗结核药物转化开发。

Quantification of Natural Growth of Two Strains of Mycobacterium Marinum for Translational Antituberculosis Drug Development.

机构信息

Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.

Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands.

出版信息

Clin Transl Sci. 2020 Nov;13(6):1060-1064. doi: 10.1111/cts.12793. Epub 2020 May 10.

DOI:10.1111/cts.12793
PMID:32267997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7719371/
Abstract

The zebrafish infected with Mycobacterium marinum (M. marinum) is an attractive tuberculosis disease model, showing similar pathogenesis to Mycobacterium tuberculosis (M. tuberculosis) infections in humans. To translate pharmacological findings from this disease model to higher vertebrates, a quantitative understanding of the natural growth of M. marinum in comparison to the natural growth of M. tuberculosis is essential. Here, the natural growth of two strains of M. marinum, E11 and M , is studied over an extended period using an established model-based approach, the multistate tuberculosis pharmacometric (MTP) model, for comparison to that of M. tuberculosis. Poikilotherm-derived strain E11 and human-derived strain M were grown undisturbed up to 221 days and viability of cultures (colony forming unit (CFU)/mL) was determined by plating at different time points. Nonlinear mixed effects modeling using the MTP model quantified the bacterial growth, the transfer among fast, slow, and non-multiplying states, and the inoculi. Both strains showed initial logistic growth, reaching a maximum after 20-25 days for E11 and M , respectively, followed by a decrease to a new plateau. Natural growth of both E11 and M was best described with Gompertz growth functions. For E11, the inoculum was best described in the slow-multiplying state, for M in the fast-multiplying state. Natural growth of E11 was most similar to that of M. tuberculosis, whereas M showed more aggressive growth behavior. Characterization of natural growth of M. marinum and quantitative comparison with M. tuberculosis brings the zebrafish tuberculosis disease model closer to the quantitative translational pipeline of antituberculosis drug development.

摘要

感染海分枝杆菌(Mycobacterium marinum,M. marinum)的斑马鱼是一种有吸引力的结核病疾病模型,其发病机制与人类分枝杆菌(Mycobacterium tuberculosis,M. tuberculosis)感染相似。为了将该疾病模型中的药理学发现转化为高等脊椎动物,定量了解海分枝杆菌与结核分枝杆菌的自然生长情况至关重要。在这里,使用已建立的基于模型的方法——多状态结核药代动力学(multistate tuberculosis pharmacometric,MTP)模型,对两种海分枝杆菌菌株 E11 和 M 的自然生长进行了长达 221 天的扩展研究,并与结核分枝杆菌进行了比较。来源于变温动物的菌株 E11 和来源于人类的菌株 M 未经干扰地生长,直至 221 天,并通过不同时间点的平板培养来确定培养物的存活率(菌落形成单位(colony forming unit,CFU)/mL)。使用 MTP 模型进行非线性混合效应建模,定量了细菌的生长、快速、缓慢和非倍增状态之间的转移以及接种物。两种菌株均表现出初始逻辑增长,E11 和 M 分别在 20-25 天后达到最大值,随后下降到新的平台。E11 和 M 的自然生长均最好用 Gompertz 生长函数来描述。对于 E11,接种物最好在缓慢倍增状态下描述,对于 M,最好在快速倍增状态下描述。E11 的自然生长与结核分枝杆菌最相似,而 M 则表现出更为激进的生长行为。海分枝杆菌自然生长的特征描述以及与结核分枝杆菌的定量比较,使斑马鱼结核病疾病模型更接近抗结核药物开发的定量转化管道。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa9e/7719371/3d00c630c604/CTS-13-1060-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa9e/7719371/3d00c630c604/CTS-13-1060-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa9e/7719371/3d00c630c604/CTS-13-1060-g001.jpg

相似文献

1
Quantification of Natural Growth of Two Strains of Mycobacterium Marinum for Translational Antituberculosis Drug Development.两种海洋分枝杆菌天然生长的定量研究 为抗结核药物转化开发。
Clin Transl Sci. 2020 Nov;13(6):1060-1064. doi: 10.1111/cts.12793. Epub 2020 May 10.
2
Screening of anti-mycobacterial compounds in a naturally infected zebrafish larvae model.在天然感染的斑马鱼幼虫模型中筛选抗分枝杆菌化合物。
J Antimicrob Chemother. 2017 Feb;72(2):421-427. doi: 10.1093/jac/dkw421. Epub 2016 Oct 24.
3
A mycobacterial phosphoribosyltransferase promotes bacillary survival by inhibiting oxidative stress and autophagy pathways in macrophages and zebrafish.一种分枝杆菌磷酸核糖基转移酶通过抑制巨噬细胞和斑马鱼中的氧化应激和自噬途径来促进细菌存活。
J Biol Chem. 2015 May 22;290(21):13321-43. doi: 10.1074/jbc.M114.598482. Epub 2015 Mar 30.
4
Zebrafish-Mycobacterium marinum model for mycobacterial pathogenesis.用于分枝杆菌致病机制研究的斑马鱼-海分枝杆菌模型
FEMS Microbiol Lett. 2003 Aug 29;225(2):177-82. doi: 10.1016/S0378-1097(03)00446-4.
5
Heterologous Expression of and in Mycobacterium marinum Enables the Rapid Identification of New Prodrugs Active against Mycobacterium tuberculosis.在海分枝杆菌中异源表达和 ,可快速鉴定新型抗结核分枝杆菌前药。
Antimicrob Agents Chemother. 2021 Mar 18;65(4). doi: 10.1128/AAC.01445-20.
6
Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.鉴定一种新型异柠檬酸裂解酶抑制剂作为针对活性和非复制性结核分枝杆菌的强效抗结核药物。
Tuberculosis (Edinb). 2016 Mar;97:38-46. doi: 10.1016/j.tube.2015.12.003. Epub 2016 Jan 6.
7
A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effects in vitro.一种多状态结核病药代动力学模型:体外研究抗结核药物作用的框架。
J Antimicrob Chemother. 2016 Apr;71(4):964-74. doi: 10.1093/jac/dkv416. Epub 2015 Dec 24.
8
The zebrafish model of tuberculosis - no lungs needed.结核分枝杆菌斑马鱼模型——无需肺部。
Crit Rev Microbiol. 2018 Nov;44(6):779-792. doi: 10.1080/1040841X.2018.1523132. Epub 2019 Jan 21.
9
The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.基因组差异区域4(RD4)对分枝杆菌毒力及卡介苗效力的影响
Front Cell Infect Microbiol. 2017 Jun 8;7:239. doi: 10.3389/fcimb.2017.00239. eCollection 2017.
10
Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis.海鱼分枝杆菌与结核分枝杆菌的比较发病机制
Cell Microbiol. 2008 May;10(5):1027-39. doi: 10.1111/j.1462-5822.2008.01133.x. Epub 2008 Feb 20.

引用本文的文献

1
Genome-wide phenotypic insights into mycobacterial virulence using Drosophila melanogaster.利用黑腹果蝇对分枝杆菌毒力进行全基因组表型分析
PLoS Pathog. 2025 Sep 5;21(9):e1013474. doi: 10.1371/journal.ppat.1013474. eCollection 2025 Sep.
2
Standardization of zebrafish drug testing parameters for muscle diseases.斑马鱼肌肉疾病药物测试参数的标准化。
Dis Model Mech. 2024 Jan 1;17(1). doi: 10.1242/dmm.050339. Epub 2024 Jan 18.
3
Implementing best practices on data generation and reporting of assays within the ERA4TB consortium.

本文引用的文献

1
Drug Effect of Clofazimine on Persisters Explains an Unexpected Increase in Bacterial Load in Patients.氯法齐明对持留菌的药物作用解释了患者细菌载量的意外增加。
Antimicrob Agents Chemother. 2020 Apr 21;64(5). doi: 10.1128/AAC.01905-19.
2
Translational Model-Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical Development.转化模型指导的早期临床开发中结核病药物组合方案选择方法。
Clin Pharmacol Ther. 2020 Aug;108(2):274-286. doi: 10.1002/cpt.1814. Epub 2020 Apr 2.
3
Transforming Translation Through Quantitative Pharmacology for High-Impact Decision Making in Drug Discovery and Development.
在ERA4TB联盟内实施关于检测数据生成和报告的最佳实践。
iScience. 2023 Mar 15;26(4):106411. doi: 10.1016/j.isci.2023.106411. eCollection 2023 Apr 21.
4
Drug Resistance in Nontuberculous Mycobacteria: Mechanisms and Models.非结核分枝杆菌中的耐药性:机制与模型
Biology (Basel). 2021 Jan 29;10(2):96. doi: 10.3390/biology10020096.
5
Anti-tuberculosis effect of isoniazid scales accurately from zebrafish to humans.异烟肼的抗结核作用在从斑马鱼到人类的范围内都能得到准确衡量。
Br J Pharmacol. 2020 Dec;177(24):5518-5533. doi: 10.1111/bph.15247. Epub 2020 Nov 3.
通过定量药理学转变翻译,以在药物发现和开发中做出高影响力决策。
Clin Pharmacol Ther. 2020 Jun;107(6):1285-1289. doi: 10.1002/cpt.1667. Epub 2019 Nov 10.
4
Forecasting Clinical Dose-Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin.从结核病研究的临床前研究中预测临床剂量反应:利福平的转化预测。
Clin Pharmacol Ther. 2018 Dec;104(6):1208-1218. doi: 10.1002/cpt.1102. Epub 2018 Jun 19.
5
Outside-In Systems Pharmacology Combines Innovative Computational Methods With High-Throughput Whole Vertebrate Studies.外成系统药理学将创新的计算方法与高通量全脊椎动物研究相结合。
CPT Pharmacometrics Syst Pharmacol. 2018 May;7(5):285-287. doi: 10.1002/psp4.12297. Epub 2018 Apr 25.
6
Decoding the similarities and differences among mycobacterial species.解读分枝杆菌属各菌种之间的异同。
PLoS Negl Trop Dis. 2017 Aug 30;11(8):e0005883. doi: 10.1371/journal.pntd.0005883. eCollection 2017 Aug.
7
Targeting Phenotypically Tolerant Mycobacterium tuberculosis.针对表型耐受的结核分枝杆菌。
Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TBTB2-0031-2016.
8
The multistate tuberculosis pharmacometric model: a semi-mechanistic pharmacokinetic-pharmacodynamic model for studying drug effects in an acute tuberculosis mouse model.多州结核病药代动力学模型:一种用于研究急性结核病小鼠模型中药物效应的半机制药代动力学-药效学模型。
J Pharmacokinet Pharmacodyn. 2017 Apr;44(2):133-141. doi: 10.1007/s10928-017-9508-2. Epub 2017 Feb 15.
9
Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics.连续数据药代动力学模型的模型评估:指标与图形
CPT Pharmacometrics Syst Pharmacol. 2017 Feb;6(2):87-109. doi: 10.1002/psp4.12161. Epub 2017 Feb 10.
10
Application of the Multistate Tuberculosis Pharmacometric Model in Patients With Rifampicin-Treated Pulmonary Tuberculosis.多状态结核病药代动力学模型在利福平治疗的肺结核患者中的应用。
CPT Pharmacometrics Syst Pharmacol. 2016 May;5(5):264-73. doi: 10.1002/psp4.12079. Epub 2016 May 17.